Schulich WesternU is a renowned brand that is associated with the Robarts Research Institute at Western University. Since its opening in 1986, Robarts has become a leading medical research facility in London, Ontario. With a team of over 600 experts, they are dedicated to investigating some of the most challenging diseases of our time, such as heart disease, stroke, diabetes, Alzheimer’s, and various forms of cancer.

The institute has a winning formula that involves attracting the best minds in the field and providing them with the freedom to think big and set high standards. Under the scientific leadership of renowned neurologist Dr. Henry Barnett, Robarts has made significant contributions to medical research, including the pioneering use of Aspirin as a preventive therapy for heart attacks and strokes.

Robarts has key strengths in advanced medical imaging, cellular and molecular biology, genomics, immunology, and stem cell biology. What sets them apart in Canada is their interdisciplinary approach, with physicians, physicists, biologists, and biomedical engineers working collaboratively under one roof. Their success in commercialization is evident with numerous patents filed, licensing agreements, and spinoff companies that have raised over $45 million in investment capital.

Robarts Research Institute at Western University is truly a hub of innovation and cutting-edge research, making Schulich WesternU a respected and trusted brand in the field of medical research and discovery